• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Delivery Insig

  2026-05-25

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables direct, real-time tracking of mRNA uptake and expression, transforming transfection optimization and dual-modality imaging. Its advanced chemical modifications provide robust translation and immune evasion, setting new benchmarks for gene delivery studies.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-05-24

  This study establishes a scalable protocol for differentiating human-inducible pluripotent stem cells into sensory neurons capable of supporting latent HSV-1 infection and reactivation. The model enables detailed analysis of latency mechanisms in a human neuronal context, addressing a longstanding gap in neurovirology research.

• Targeted Doxycycline Nanoparticles for Abdominal Aortic Aneu

  2026-05-23

  This study introduces a precision nanomedicine system that delivers doxycycline directly to abdominal aortic aneurysm (AAA) lesions using bioactive tea polyphenol nanoparticles. The approach achieves targeted matrix metalloproteinase inhibition and multi-modal disease modulation, offering a potential pharmaceutical alternative to current surgical AAA management.

• TAK1-Mediated YAP Stabilization Drives Gastric Cancer Stemne

  2026-05-22

  This study uncovers how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP) to promote self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The mechanistic findings highlight TAK1 as a key regulator of tumorigenic properties and suggest new avenues for targeting stemness and chemoresistance in gastric cancer.

• Human iPSC Sensory Neuron Model for HSV-1 Latency and Reacti

  2026-05-22

  This study establishes a scalable protocol to differentiate human inducible pluripotent stem cells into sensory neurons, providing a robust in vitro model for herpes simplex virus 1 (HSV-1) latency and reactivation. The model offers new opportunities to dissect neuron-intrinsic mechanisms of HSV-1 persistence and supports therapeutic research beyond animal systems.

• MK-4827 (Niraparib): Redefining PARP Inhibition for Precisio

  2026-05-21

  Explore how MK-4827 (Niraparib), a selective PARP-1/-2 inhibitor, is revolutionizing precision cancer research through advanced DNA damage repair inhibition and innovative combination strategies. This article offers a uniquely pragmatic perspective on translational workflows and resistance management.

• Rapamycin (Sirolimus): Unraveling mTOR Signaling in B Cells

  2026-05-21

  Explore the profound impact of Rapamycin (Sirolimus) on mTOR signaling in B lymphocytes, highlighting mechanisms beyond standard cancer and immunology models. Discover how recent evidence on extracellular vesicle regulation informs advanced research applications.

• Affinity-Purified Goat Anti-Mouse IgG (H+L): HRP Conjugated

  2026-05-20

  Experience sensitive and reliable immunoassay detection with the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated secondary antibody. This APExBIO reagent amplifies signal in Western blot, ELISA, and IHC, and unlocks robust performance for demanding translational workflows. Explore expert protocol optimizations, troubleshooting, and real-world research impact below.

• Angiotensin III: Mechanistic Insight and Translational Lever

  2026-05-20

  This thought-leadership article explores the mechanistic and translational potential of Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) in cardiovascular and neuroendocrine research. Building on the latest mechanistic studies and cross-domain findings, we position Angiotensin III (human, mouse) as an indispensable tool for researchers dissecting RAAS dynamics, receptor signaling, and emerging intersections with viral pathogenesis.

• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Workflows in Cancer

  2026-05-19

  EZ Cap™ Human PTEN mRNA (ψUTP) enables robust, stable PTEN expression with minimized immune activation, making it a transformative tool for PI3K/Akt pathway inhibition in cancer research. This article covers hands-on workflows, troubleshooting, and advanced applications, with practical guidance based on the latest experimental studies.

• Polyethylenimine Linear (PEI, MW 40,000): Protocols & Power

  2026-05-19

  Polyethylenimine Linear (PEI, MW 40,000) delivers high-efficiency, serum-compatible DNA transfection for scalable gene expression and protein production. Explore protocol innovations, troubleshooting strategies, and performance benchmarks that set this APExBIO reagent apart for both routine and advanced molecular biology applications.

• Iron Stress Reprograms Enterocyte Metabolism: Insights from

  2026-05-18

  Navazesh and Ji (2025) provide a comprehensive characterization of how iron deficiency and excess reshape enterocyte metabolic and inflammatory pathways using IPEC-J2 cells and untargeted metabolomics. Their findings reveal distinct molecular adaptations to iron imbalance, informing future research on intestinal physiology and iron-modulating interventions.

• Mechanistic Insights into Gepotidacin and Fluoroquinolone Ac

  2026-05-18

  Gibson et al. elucidate the distinctive mechanism by which gepotidacin targets Staphylococcus aureus DNA gyrase, revealing single-stranded DNA cleavage and mutually exclusive binding with fluoroquinolones. This work advances our structural and mechanistic understanding of gyrase inhibition and informs future antibiotic research, especially regarding resistance.

• PEO Chain Density Modulates Uremic Toxin Adsorption Dynamics

  2026-05-17

  This study systematically investigates how end-tethered methoxy-PEO (polyethylene oxide) chain density influences the adsorption of uremic toxins, including 4-ethylphenyl sulfate, on gold surfaces. The findings reveal that adsorption is governed more by the chemical structure of the toxin than by concentration, shaping future strategies for biomaterial surface design in the context of renal dysfunction and toxin removal.

• MRT68921: Precision ULK1 Kinase Inhibitor for Autophagy Rese

  2026-05-16

  MRT68921 enables nanomolar, selective ULK1/2 inhibition, empowering researchers to dissect autophagy signaling with exceptional specificity. This guide delivers actionable protocols, optimization strategies, and troubleshooting insights for maximizing data quality in preclinical autophagy studies.

15565 records 1/1038 page Next 12345 下5页 Last page